Our study provides important insights into the modulation of galectin-3 levels by metformin dosage and hyperprolactinemia in women with PCOS, highlighting the relevance of patient-specific treatment strategies for addressing the complex metabolic and hormonal challenges of this condition. The gene discussed is LGALS3; the disease is polycystic ovary syndrome.